David Geffen School of Medicine — Los Angeles, California

Public research footprint of David Geffen School of Medicine, compiled from the ClinicalTrials.gov public registry.

287

Registered studies

Active

Recruiting now

174

Completed

Stopped or withdrawn

Most-studied conditions

Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation · Diffuse Large B-cell Lymphoma (DLBCL) · Developmental and Epileptic Encephalopathy · Transthyretin Amyloidosis

Recently updated registry entries

NCT07207876 — Study of Ceftriaxone and Benzathine Penicillin G During Pregnancy (Recruiting)
NCT02140255 — Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission (Recruiting)
NCT06091865 — A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at David Geffen School of Medicine?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.